Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes

@article{Torren2016SerumCA,
  title={Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes},
  author={C. R. van der Torren and A. V. Verrijn Stuart and Dahae Lee and J. Meerding and Ursule van de Velde and D. Pipeleers and P. Gillard and B. Keymeulen and W. de Jager and B. Roep},
  journal={PLoS ONE},
  year={2016},
  volume={11}
}
Background Islet cell transplantation holds a potential cure for type 1 diabetes, but many islet recipients do not reach long-lasting insulin independence. In this exploratory study, we investigated whether serum cytokines, chemokines and adipokines are associated with the clinical outcome of islet transplantation. Methods Thirteen islet transplant patients were selected on basis of good graft function (reaching insulin independence) or insufficient engraftment (insulin requiring) from our… Expand
Recent progress in the use and tracking of transplanted islets as a personalized treatment for type 1 diabetes
Interleukin-15 in autoimmunity.

References

SHOWING 1-10 OF 56 REFERENCES
Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation
Circulating cytokines are associated with human islet graft function in type 1 diabetes.
Islet transplantation in patients with diabetes mellitus: choice of immunosuppression.
  • S. Nanji, A. Shapiro
  • Medicine
  • BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
  • 2004
Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft
...
1
2
3
4
5
...